-+ 0.00%
-+ 0.00%
-+ 0.00%

ALNYLAM PHARMACEUTICALS : BARCLAYS CUTS TARGET PRICE TO $380 FROM $450

Reuters·11/02/2026 09:13:26

Please log in to view news